State Directory

GLP-1 Providers in Wyoming

GLP1Search tracks 48 crawl-qualified GLP-1 provider records across 16 Wyoming cities, including clinic, telehealth, med spa, and metabolic-health listings where source data is available.

Provider Records

48

Cities

16

Source-Verified

44

Public Pricing

0

Market Snapshot

Where GLP-1 care is concentrated in Wyoming

The Wyoming directory is led by Casper, Cheyenne, Gillette. Across the state, 98% of provider records include phone plus address or website coverage, 0% list public pricing, and 92% are marked source-verified.

Data Complete

98%

Pricing Visible

0%

Source Verified

92%

Top Wyoming cities for GLP-1 providers

Casper WY 11 Cheyenne WY 10 Gillette WY 7 Jackson WY 5 Laramie WY 2 Sheridan WY 2 Thayne WY 2 Cody WY 1 Evansville WY 1 Kemmerer WY 1 Pinedale WY 1 Powell WY 1

Featured provider records in Wyoming

Remède IV Therapy + Aesthetics - Jackson Hole Jackson GLP-1 provider Melt Medspa Cheyenne GLP-1 provider Adora Day Spa Cheyenne GLP-1 provider True Body Medical Spa Cody GLP-1 provider Shekinah Clinical Spa Gillette GLP-1 provider Anova Med Spa Sheridan GLP-1 provider June Beauty Lab Pinedale GLP-1 provider Nurse Jayme Aesthetics Thayne GLP-1 provider Expansion Health Jackson GLP-1 provider Evergreen Aesthetics Jackson GLP-1 provider Aesthetics By Summit Gillette GLP-1 provider The Gym Aesthetics Sheridan GLP-1 provider

All covered cities in Wyoming

Casper 11 Cheyenne 10 Cody 1 Evansville 1 Gillette 7 Jackson 5 Kemmerer 1 Laramie 2 Pinedale 1 Powell 1 Rawlins 1 Riverton 1 Rock Springs 1 Sheridan 2 Thayne 2 Wilson 1

Questions about GLP-1 providers in Wyoming

How many providers are listed?

GLP1Search lists 48 crawl-qualified GLP-1 provider records across 16 cities in Wyoming.

Which cities have the most listings?

Casper (11), Cheyenne (10), Gillette (7), Jackson (5), Laramie (2) currently have the highest listing density in Wyoming.

What should patients compare?

Compare licensed clinical oversight, medication source, pharmacy type, public pricing, follow-up cadence, side-effect support, and whether the clinic documents semaglutide or tirzepatide availability.